Natera: Early cancer detection via DNA blood tests becomes a mass market

Blood instead of biopsy: customized DNA blood tests for cancer, pregnancy, and transplants – with growing reimbursement by US insurers as a lever for recurring revenues. New all-time high despite current market correction Natera is a diagnostics specialist based in Austin that stands at an exciting turning point: the company has early on focused on detecting diseases through freely circulating DNA in the blood. What initially seemed like an exotic idea has transformed into a business across three major medical fronts – cancer, pregnancy...